octanine süstelahuse pulber ja lahusti
octapharma (ip) - ix hüübimisfaktor - süstelahuse pulber ja lahusti - 500rÜ 1tk
triumeq
viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - hiv-nakkused - viirusevastased ravimid süsteemseks kasutamiseks - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.
zepatier
merck sharp & dohme b.v. - elbasvir, grazoprevir - c-hepatiit, krooniline - direct acting antivirals, antivirals for systemic use, antivirals for treatment of hcv infections - zepatier is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients 12 years of age and older who weigh at least 30 kg (see sections 4. 2, 4. 4 ja 5. c-hepatiidi viiruse (hcv) genotüüp-eriaktiivsus vt lõigud 4. 4 ja 5.
visudyne
cheplapharm arzneimittel gmbh - verteporfiin - myopia, degenerative; macular degeneration - oftalmoloogilised vahendid - visudyne on näidustatud ravi:täiskasvanutele eksudatiivne (märg) vanusega seotud makuladegeneratsiooni (amd) koos peamiselt klassikaline subfoveal choroidal neovascularisation (cnv) või;täiskasvanute subfoveal choroidal neovascularisation teisejärguline patoloogiline lühinägevus.
kaftrio
vertex pharmaceuticals (ireland) limited - ivacaftor, tezacaftor, elexacaftor - tsüstiline fibroos - muud hingamisteede tooted - kaftrio is indicated in a combination regimen with ivacaftor for the treatment of cystic fibrosis (cf) in patients aged 6 years and older who have at least one f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene.
calquence
astrazeneca ab - acalabrutinib - leukeemia, lümfotsüütne, krooniline, b-rakk - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.
apretude
viiv healthcare b.v. - cabotegravir - hiv-nakkused - viirusevastased ravimid süsteemseks kasutamiseks - apretude is indicated in combination with safer sex practices for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 infection in high-risk adults and adolescents, weighing at least 35 kg (see sections 4. 2, 4. 4 ja 5.
esmya
gedeon richter ltd - ulipristaalatsetaat - leiomüoom - suguhormoonid ja genitaalsüsteemi, - ulipristaalatsetaat on näidustatud emaka fibroidide mõõdukate või raskekujuliste sümptomite eelravis reproduktiivset vanust täiskasvanud naistel. ulipristal taat on näidustatud vahelduva mõõdukate kuni raskete sümptomite emaka fibroidid täiskasvanud naiste reproduktiivse vanus.
nebivolol-teva tablett
teva pharma b.v. - nebivolool - tablett - 5mg 50tk; 5mg 20tk; 5mg 7tk; 5mg 90tk; 5mg 14tk; 5mg 100tk; 5mg 30tk; 5mg 10tk; 5mg 28tk; 5mg 60tk; 5mg 120tk
ledipin õhukese polümeerikattega tablett
teva pharma b.v. - lerkanidipiin - õhukese polümeerikattega tablett - 10mg 56tk; 10mg 30tk; 10mg 28tk; 10mg 98tk; 10mg 50tk; 10mg 14tk